Osteoporosis drug may cure heart too

According to the research reports made on the patients who had a hip fracture from 2005 through 2013 were followed until late 2016. 4602(13%) of total 34,991 patients were given osteoporosis treatment during follow-up.

The patients who have undergone osteoporosis treatment they faced reduced risk of cardiovascular death, heart attack, and stroke, proved in a study of patients with hip fractures. The association of researchers was seen for up to 10 years after fracture.

Researchers connected Alendronate with 67% and 45% lower risks of one-year cardiovascular death and heart attack, respectively. Senior author Ching-Lung Cheung said that it is well known that there is a worldwide lack in the treatment of osteoporosis, as patients are not aware with the rare side effects. Researchers’ work report proved that alendronate is potentially cardioprotective in hip fracture patients.

Therefore, doctors should start prescribing alendronate or other nitrogen-containing bisphosphonates to the hip fractured patients immediately after their fracture, and patients should also have good compliance with alendronate treatment, as this is not only good for their bones but also for their heart.

This complete research study is published in the Journal of Bone and Mineral Research.

Related Posts

MedTech Zone AMTZ Puts Vizag on the Science Map of India

Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

  • Health
  • June 11, 2025
  • 531 views
Doctors trialling ‘poo pills’ to flush out dangerous superbugs

UK doctors are attempting to clear dangerous superbug infections using “poo pills” containing freeze-dried faeces. The stool samples come from healthy donors and are packed with good bacteria. Early data…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

License Of Four Pharma Firms Cancelled For Illegal Drug Trade In Jammu & Kashmir

License Of Four Pharma Firms Cancelled For Illegal Drug Trade In Jammu & Kashmir

Pharmexcil flags export disruption risk due to COPP mandate; seeks urgent review

Pharmexcil flags export disruption risk due to COPP mandate; seeks urgent review

Maharashtra rolls back order allowing homeopaths to practise allopathy, forms review panel

Maharashtra rolls back order allowing homeopaths to practise allopathy, forms review panel

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact